Drug Profile
Prostaglandin J2
Alternative Names: PGJ2Latest Information Update: 23 Aug 2002
Price :
$50
*
At a glance
- Originator University of Rome
- Developer Cayman Chemical; University of Rome
- Class Antineoplastics; Prostaglandins
- Mechanism of Action Prostaglandin D agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Aug 1998 Profile reviewed
- 11 Nov 1994 Preclinical development for Cancer in Italy (Unknown route)
- 11 Nov 1994 Preclinical development for Cancer in USA (Unknown route)